Sign in
Clinico-immunologic aspects of botulinum toxin type B treatment of cervical dystonia
Journal article   Peer reviewed

Clinico-immunologic aspects of botulinum toxin type B treatment of cervical dystonia

J JANKOVIC, C HUNTER, C SINGER, M STACY, D TARSY, M. Z ATASSI, B. Z DOLIMBEK, G. S DOLIMBEK, C. H ADLER, A BRASHEAR, …
Neurology, Vol.67(12), pp.2233-2235
2006
PMID: 17190952

Abstract

Neurology Biological and medical sciences Muscle Medical sciences Diseases of striated muscles. Neuromuscular diseases Pharmacology. Drug treatments

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.247 Migraines & Headaches
1.247.1001 Dystonia
Web Of Science research areas
Clinical Neurology
ESI research areas
Neuroscience & Behavior

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details